echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > 97 countries talk about varieties directly linked to the net.

    97 countries talk about varieties directly linked to the net.

    • Last Update: 2020-08-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    ▍ negotiated drugs, directly linked to the net Yesterday, the State Health Insurance Administration, the National Health and Health Commission jointly issued "on doing a good job in the 2019 National Health Insurance Negotiations drug landing notice", requiring 97 negotiated drugs in the prescribed time limit in the provincial drug centralized procurement platform directly linked to the network.
    timely organize medical institutions and pharmaceutical production enterprises to sign agreements, medical institutions in accordance with the agreement norms procurement.
    notice shows that the co-ordination of regional medical insurance agencies should be transferred in and out of the new version of the drug situation to speed up the adjustment and updating of the medical insurance information system, the formulation of settlement management methods, to ensure that the new version of the catalog timely landing.
    to improve the fine management capacity and level, in determining the annual total amount control index of fixed-point medical institutions, we should consider the new version of the catalog drug increase and decrease, structural adjustment and the characteristics of fixed-point medical institutions and other factors, reasonable calculation of the amount of fund payment, to protect medical institutions and patients basic drug needs.
    it is worth noting that in order to ensure the timely entry of negotiated drugs into fixed-point medical institutions, local medical insurance, health and health departments should, in accordance with their duties, put forward specific requirements for the provision and use of negotiated drugs, guide the fixed-point medical institutions according to functional positioning, clinical needs and diagnostic and treatment capacity, such as timely equipment, rational use, not to the total amount of medical insurance control, medical institutions drug catalog restrictions, drug proportion, etc. as the reasons for the negotiation of drug equipment, use.
    in addition, each fixed-point medical institution shall, in accordance with the catalogue of the situation of drug transfer, timely convening a special drug management meeting, the medical institutions to adjust and optimize the drug catalog.
    ▍ encourage alternatives In addition to being admitted to hospital, the notice clearly states that local health insurance departments should be scientifically measured and well organized to actively explore payment methods that are in line with local practices on the premise of ensuring the safety of funds and the rational use of medicines.
    for negotiated drugs suitable for outpatient treatment, long life cycle and high cost of treatment, the burden of patients can be reduced by including outpatient special disease protection and exploring single-disease payments, according to the fund's income and expenditure.
    where conditions exist, long-term prescription policies can be actively explored to facilitate patient use.
    measures may be taken to encourage alternative use of the original cost-effective, completely replaceable medicines in the pre-negotiation health insurance catalogue.
    that is, as long as the drugs located in the current negotiating list, as long as the country talks the variety of more cost-effective, can be used instead.
    ▍ strengthen monitoring, state-to-state drug use Local governments should establish a negotiated drug use monitoring mechanism, strengthen statistical monitoring of drug provision, use and payment of negotiated drugs, and report monthly to the National Health Insurance Administration (Pharmaceutical Services Management Department) in January-June 2020.
    health departments at all levels should strengthen the management and guidance of medical institutions, improve the negotiation of guidelines and norms for drug use, standardize the conduct of diagnosis and treatment, and promote rational drug use.
    all fixed-point medical institutions should work together to strengthen drug management to ensure the rational and standardized use of negotiated drugs.
    notice indicates that the provinces should report the progress of the relevant work in a timely manner as required, and the state will prompt and inform the provinces that are slow and do not implement the policy within the prescribed time limit.
    the National Health Insurance Administration will select some of the overall areas in the country to focus on monitoring the use of the new version of the catalog adjustment, specific requirements for further notice.
    soon, the National Health Insurance Administration will issue relevant documents to monitor the use of drugs in the new catalog, the state to strengthen monitoring efforts, which for many successful negotiations of pharmaceutical companies, is to promote the upper amount of good.
    ▍ these drugs, ushered in a new round of release recently, the 2019 health insurance negotiations drug catalog was officially announced, 150 drugs into 97, all included in the scope of the catalog Of Class B drugs.
    , 70 of the 119 drugs were successfully negotiated, with an average price reduction of 60.7 per cent, and 27 drugs were successfully "renewed".
    according to Fengyun drug talk statistics, has been announced 50 products, all of the decline is larger, nearly 12% of the products fell by more than 80%, 48% of the drugs in the 50-80%.
    (source: Fengyun medicine talk) to the first batch of 36 negotiated catalog sales data, it has been into health insurance sales for more than 1 year, from the sample hospital data, most of the varieties in 2018 sales to achieve more than 100% growth, into the health insurance to release is very obvious;
    it is understood that most of the varieties are pharmaceutical companies' exclusive products, into the health insurance, will be the follow-up to the product sales and competition has no small impact.
    it should be noted that after the implementation of the national medical insurance drug catalogue, the provinces and cities can no longer be added and adjusted, nor can it adjust the limited payment scope of drugs in the catalogue.
    that is to say, drug adjustment is in principle decided by the state, the abolition of the local medical insurance catalogue, and the payment management of medical insurance drugs have been strictly regulated, enhanced supervision and guidance on the use of drugs.
    set more precise and strict limits on payment scope sharply to minimize unreasonable spending.
    for example, the other day, Hunan Province health insurance will clearly transfer 404 varieties, of which 212 Western medicine, 192 traditional Chinese medicine.
    a number of attempts to enter the health insurance catalog through local health insurance supplements, there is no room for manoeuvre, the representatives involved, agents, then to start thinking about the future way out.
    attached to the 97 successful drugs in the negotiation list of the original title: the National Health Insurance Administration, the Health and Care Commission named 97 large varieties: Acapo sugar, engler net, golden flower clear-sensitive particles ...
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.